Emcure Pharmaceuticals to Distribute Roche's Nephrology and Transplant Products in India

Emcure Pharmaceuticals has signed a distribution agreement with Roche to distribute select nephrology and transplant medicines in India, effective April 1, 2026. The agreement includes Roche's immunosuppressant CellCept and anemia treatments Mircera and Neorecormon, aimed at expanding patient access to therapies for chronic kidney disease, anemia management, and transplant care. Both companies highlighted Emcure's strong distribution network and the partnership's potential to improve treatment availability nationwide.